An observational study in Occupational Diseases, sponsored by Sergio Gabriel Susmallian. Completed at 1 site in Israel. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-16.
Sponsored by Sergio Gabriel Susmallian · Observational
This clinical study aims to evaluate the effectiveness and safety of [intervention or treatment] in patients with [clinical condition]. The study will investigate whether this intervention improves [primary clinical outcome] compared with [standard treatment or control group]. Participants will undergo clinical assessment and follow-up according to the study protocol. The findings may provide additional evidence regarding the clinical effectiveness, safety, and potential benefits of this treatment.
This study is designed to investigate the clinical effectiveness and safety of [intervention] in patients diagnosed with [clinical condition]. The primary objective is to evaluate the effect of the intervention on [primary outcome]. Secondary objectives include the assessment of [secondary outcomes], treatment-related complications, and other relevant clinical parameters.
Eligible participants will be enrolled according to predefined inclusion and exclusion criteria. Participants will receive [description of intervention], and clinical outcomes will be assessed using standardized evaluation methods at predetermined follow-up intervals.
Data will be collected prospectively and analyzed to assess the primary and secondary study outcomes. Safety assessments will include the documentation of adverse events and treatment-related complications.
49 studies on the registry are indexed under Occupational Diseases; 12 are open to participants now.
This study's enrollment of 1,951 is above the median of 255 across 23 observational studies indexed under Occupational Diseases.
Browse Occupational Diseases studies →Sergio Gabriel Susmallian is the lead sponsor of 5 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study population comprises individuals with occupational claims related to exposure to hazardous substances recorded in the National Insurance Institute of Israel administrative database between January 1, 2018, and December 31, 2025. The nationwide dataset includes information on demographic characteristics, geographic distribution, exposure-related diagnoses, medical assessments, temporary and permanent disability determinations, assigned disability severity, and compensation classifications. Solar and sunlight-related conditions are excluded from the diagnostic analysis. The study includes all eligible administrative records without additional participant recruitment or clinical interventions.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Workers with occupational claims related to exposure to hazardous chemical substances and other non-solar hazardous agents recorded in the National Insurance Institute of Israel database between January 2018 and December 2025. The study includes administrative information on demographic characteristics, occupational exposure-related diagnoses, geographic distribution, medical assessments, temporary and permanent disability determinations, assigned disability severity, and compensation classifications. Solar and sunlight-related conditions are excluded from the diagnostic analysis. All data were collected retrospectively from existing administrative records.
Other: Retrospective Administrative Data Assessment
Retrospective analysis of existing occupational insurance records to evaluate hazardous substance-exposure claims, associated clinical conditions, and disability outcomes. No treatment, experimental exposure, or clinical intervention is administered.
Occupational Hazardous Substance-Exposure Claim Rate
Annual number of recognized occupational hazardous substance-exposure claims per 100,000 employed persons in Israel. Rates will be calculated using annual claim counts and the average national employed population. Temporal trends will be evaluated across the study period using regression models with appropriate denominator offsets. The outcome is an administrative claim rate rather than the incidence of occupational disease or exposure.
Time frame: January 1, 2018, through December 31, 2025
Plan to share: No — Individual participant data will not be publicly shared because the study uses confidential administrative records obtained from the National Insurance Institute of Israel. Access to individual-level data is restricted by applicable privacy regulations, institutional policies, and data-use agreements. De-identified aggregate results, statistical summaries, and methodological information may be made available in scientific publications or upon reasonable request, subject to institutional approval.
Ran from Jan 2018 to primary completion in Dec 2025, 95 months.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sergio Gabriel Susmallian